Cirrhosis–Dystonia–Polycythemia–Hypermanganesemia Syndrome

Other Names
Types
Causes
Symptoms and Signs
Diagnostic Tests and Investigations
Non-pharmacological Treatments (Therapies and Others)
Drug Treatments
Dietary Molecular Supplements
Immunity-Booster / Regenerative / Stem-Cell-Related Approaches
Surgeries and Procedures
Key Preventions
When to See Doctors Urgently
Dietary “What to Eat and What to Avoid” Points
Frequently Asked Questions (FAQs)

Cirrhosis–dystonia–polycythemia–hypermanganesemia syndrome is a very rare genetic disease where the body cannot properly remove extra manganese, a metal that is normally needed in very small amounts. Because of a gene problem, manganese builds up mainly in the liver and the brain, especially in the deep movement-control areas called the basal ganglia. This build-up slowly damages these organs.

Cirrhosis–dystonia–polycythemia–hypermanganesemia syndrome (often called HMDPC) is a very rare inherited disorder caused by harmful changes in the SLC30A10 gene. This gene normally helps the body move extra manganese out of the liver and brain. When it does not work properly, manganese slowly builds up, especially in the liver and deep parts of the brain that control movement. This leads to liver scarring (cirrhosis), abnormal twisting or stiff movements (dystonia), too many red blood cells (polycythemia), and high manganese levels in blood and tissues.[1][2]

This condition is also called a manganese transporter disorder, because the affected gene (SLC30A10) normally helps move manganese out of cells so it can leave the body through bile and stool. When this gene does not work, manganese stays inside cells, blood manganese levels rise, and over time this causes liver scarring (cirrhosis), abnormal body movements (dystonia or parkinsonism), and too many red blood cells (polycythemia).

The disease usually starts in childhood or teenage years. Children may first show stiff or twisted movements, walking problems, or trouble speaking, and later may develop signs of liver disease and very high red blood cell counts. If doctors recognize it early and reduce the manganese levels, the condition can improve, so it is considered a “treatable” inborn error of manganese metabolism.

Other Names

Doctors use several other names for this syndrome. One common name is “Hypermanganesemia with dystonia, polycythemia and cirrhosis” (often shortened to HMDPC). “Hypermanganesemia” means high manganese in the blood, “dystonia” means abnormal, twisting muscle movements, “polycythemia” means too many red blood cells, and “cirrhosis” means long-standing scarring of the liver.

Another medical name is “Hypermanganesemia with dystonia 1” or HMNDYT1. This name is used in genetic databases and tells us that this is type 1 of the inherited manganese transport disorders. It is also called “SLC30A10 deficiency” because the problem lies in both copies of the SLC30A10 gene.

Some rare-disease catalogues also use the name “Cirrhosis–dystonia–polycythemia–hypermanganesemia syndrome,” which describes the four main features in one phrase. This name helps doctors remember that the same genetic problem explains the liver disease, movement disorder, high red blood count, and high manganese level.

Types

Simple “types” based on how the disease looks (not different genes, but different patterns):

Classic childhood-onset form – Symptoms start in early childhood with walking problems, dystonia of the limbs and trunk, and early polycythemia, followed later by signs of chronic liver disease such as enlarged liver or cirrhosis.
Adolescent or young-adult onset form – Some people first show movement problems and polycythemia in their teens or early adult years, and liver disease may appear later or be milder. The core gene problem is the same, but timing and severity differ.
Parkinsonian-dominant form – In a few older patients, slow movements, stiffness, and tremor (parkinsonism) are more obvious than twisting dystonia, but blood manganese is still high and the SLC30A10 mutation is present.

Causes

Here, “causes” means the main genetic cause plus related biological and family factors that lead to or worsen manganese build-up in this syndrome.

Biallelic SLC30A10 gene mutation
The main cause is a harmful change (mutation) in both copies of the SLC30A10 gene. This gene normally makes a protein that pumps manganese out of liver and intestinal cells. When both copies are faulty, the pump fails, and manganese cannot leave the body properly.
Autosomal recessive inheritance
The disease follows an autosomal recessive pattern. This means a child must receive one faulty SLC30A10 gene from each parent to become sick. Parents who each carry one faulty copy are usually healthy but have a 25% chance in every pregnancy to have an affected child.
Loss of manganese export from liver cells
SLC30A10 is active in liver cells (hepatocytes). When it does not work, manganese cannot be exported into bile, so manganese stays inside the liver and in the blood. Over many years, this manganese overload leads to liver inflammation and scarring (cirrhosis).
Loss of manganese export from intestinal cells
The gene also works in intestinal cells. Defective SLC30A10 reduces the ability of the gut to return excess manganese back into the gut lumen for removal, so more manganese enters the blood and stays there. This makes the body manganese load even higher.
Manganese build-up in the basal ganglia
Excess manganese in the blood crosses into the brain, especially into basal ganglia, which control movement. High manganese levels in these areas disturb nerve cell signaling and cause dystonia and other movement problems.
Manganese toxicity to nerve cells
Manganese at high levels is toxic to neurons. It changes energy production in mitochondria, increases oxidative stress, and interferes with dopamine and other brain chemicals, leading to parkinsonism, gait disturbance, and speech problems.
Manganese toxicity to liver cells
In the liver, chronic manganese overload triggers inflammation and fibrosis, and over years this can turn into cirrhosis, with nodular scarring and loss of normal liver structure.
Stimulation of red blood cell production (polycythemia)
Many patients have very high hemoglobin and hematocrit. Manganese overload is thought to stimulate erythropoietin or bone marrow activity, so the body makes too many red blood cells, leading to polycythemia or erythrocytosis.
Consanguineous marriage (related parents)
When parents are closely related (for example, cousins), they are more likely to carry the same rare SLC30A10 mutation. This increases the chance that a child will inherit two faulty copies and develop the syndrome.
Family history of similar illness
Having brothers, sisters, or other relatives with unexplained dystonia, very high hemoglobin, or early cirrhosis may reflect a shared SLC30A10 mutation in the family, acting as a strong background cause.
Environmental manganese exposure on top of the gene defect
People with this genetic problem may be extra sensitive to environmental manganese, such as high manganese in drinking water or diet, so even normal exposures can worsen the build-up and symptoms.
Impaired biliary excretion in co-existing liver disease
If someone with SLC30A10 deficiency develops another liver problem that further reduces bile flow, manganese excretion becomes even worse, increasing toxicity to both liver and brain.
Early-life vulnerability of the developing brain
When manganese overload starts in infancy or early childhood, the developing brain is more sensitive to injury. This early vulnerability helps explain why many patients show childhood-onset dystonia and learning problems.
Impaired interaction with other metal ions (iron and others)
Manganese transport is linked to other metals such as iron. Disturbed balance of iron transport in SLC30A10 deficiency may change how manganese is taken up or stored, which can further promote overload.
Genetic background and modifier genes
Different people with the same SLC30A10 mutation can have different severity. Other genes that control metal handling, oxidative stress, or liver repair may modify how strongly manganese overload harms tissues.
Delay in diagnosis and treatment
Because this is a rare disease, many patients are diagnosed late. The longer manganese levels stay high, the more damage accumulates in brain and liver, so late diagnosis itself becomes a practical cause of more severe disease.
Lack of chelation or iron therapy in early stages
Chelation drugs and iron therapy can help lower manganese in this condition. When they are not given, manganese continues to build up; this ongoing exposure is a cause of disease progression.
Poor nutritional status or intercurrent illness
Severe infections, poor diet, or other illnesses can stress the liver and brain. In a person with SLC30A10 deficiency, these extra stresses may make manganese injury worse and bring out symptoms earlier.
Sex- and age-related factors
Studies in patients and animal models suggest some sex differences and age-related changes in how manganese toxicity shows, which may contribute to why some individuals develop symptoms earlier or more severely.
Other manganese transporter disorders as look-alikes
Mutations in other manganese transporter genes, such as SLC39A14 and SLC39A8, cause related syndromes with manganese overload. These are not causes of this exact syndrome but are important to recognize as different conditions that share similar biology and must be ruled out when doctors are searching for the cause.

Symptoms and Signs

Generalized or focal dystonia
Many patients show twisting, repetitive movements, abnormal postures, or muscle cramps, especially in the arms, legs, neck, or trunk. These movements may worsen with action and can make standing or walking very difficult.
Gait disturbance and walking difficulty
Because of dystonia and sometimes parkinsonism, people may walk with a stiff or awkward gait, drag one leg, or need support. Over time, some may become unable to walk without help or a wheelchair.
Parkinsonian features (slowness, stiffness, tremor)
Some older patients develop symptoms that look like Parkinson’s disease: slow movements, rigid muscles, reduced arm swing, and resting tremor, due to manganese injury to movement-control circuits.
Speech problems (dysarthria)
Many individuals have slurred, slow, or strained speech. The voice may sound tight or soft, and it can be hard for others to understand them, because dystonia affects muscles of the face, tongue, and throat.
Swallowing difficulties
In more severe cases, dystonia can involve throat muscles, making it hard to swallow. This can lead to choking, weight loss, or even chest infections from food going the wrong way.
Polycythemia (very high hemoglobin and hematocrit)
A hallmark feature is an abnormally high red blood cell count. Blood tests show very high hemoglobin and hematocrit, and patients may have headaches, dizziness, or reddish skin due to thicker blood.
Enlarged liver (hepatomegaly)
On physical exam or ultrasound, the liver is often enlarged. This reflects chronic inflammation and early fibrosis caused by manganese build-up in liver cells.
Cirrhosis and signs of chronic liver disease
Over time, the liver may become cirrhotic, with scarring that cannot be reversed. Patients may show signs like fluid in the abdomen (ascites), spider veins on the skin, or bleeding problems in advanced cases.
Jaundice or abnormal liver tests
Some patients develop yellowing of the skin or eyes and have raised liver enzymes or bilirubin in blood tests, showing that the liver is under stress from manganese overload.
Fatigue and poor exercise tolerance
Even when blood counts are high, people can feel very tired because of the movement disorder, liver disease, and overall strain on the body, which together reduce energy and stamina.
Seizures in some patients
A few case reports describe seizures in children with SLC30A10 mutations and hypermanganesemia. Seizures may reflect more widespread brain involvement in severe cases.
Learning or school difficulties
Children may have trouble keeping up at school, either due to direct effects of manganese on cognition or because movement problems and fatigue make concentrating and writing difficult.
Emotional or behavioral changes
Some individuals experience mood changes, irritability, or low mood. Living with a chronic movement and liver disease also adds psychological stress, which can affect behavior.
Weight loss or poor growth
Because swallowing can be difficult and liver disease can affect nutrition, some children may grow poorly or lose weight, especially when symptoms are advanced.
Abnormal muscle tone and reflexes on exam
Neurological examination may show increased muscle tone, brisk reflexes, or other signs of pyramidal tract involvement along with dystonia, reflecting complex manganese effects on the nervous system.

Diagnostic Tests and Investigations

In this syndrome, doctors combine information from the history, physical exam, lab tests, imaging, and genetic studies.

Physical Examination Tests

General physical and growth examination
The doctor checks height, weight, body build, and vital signs, and looks for features such as jaundice, enlarged abdomen, or visible blood vessels on the skin, which may suggest chronic liver disease and guide further testing.
Neurological examination for dystonia and parkinsonism
A detailed nerve and muscle exam looks for abnormal postures, twisting movements, tremor, slowness, muscle stiffness, and balance problems. These findings help distinguish this manganese-related dystonia from other movement disorders.
Examination of gait and posture
The doctor watches how the patient stands, walks, turns, and sits down. Characteristic gait patterns, such as dragging a leg or twisted foot posture, are important bedside clues to a dystonic condition.
Abdominal examination for liver and spleen size
By feeling the abdomen, the clinician can detect an enlarged liver or spleen, fluid in the abdomen, or tenderness. These signs point toward chronic liver disease from manganese build-up.
Eye and skin examination
Doctors check for yellow eyes or skin (jaundice), pallor, or other skin signs of chronic liver disease. These visible signs are simple but helpful early indicators of liver involvement.

Manual / Bedside Neurological Tests

Manual muscle strength testing
The doctor asks the patient to push and pull against resistance in arms and legs. This simple test checks whether weakness is present in addition to dystonia or stiffness, which helps separate this condition from primary muscle diseases.
Coordination tests (finger–nose, heel–shin)
Simple bedside coordination tests, such as touching the finger to the nose or sliding the heel along the shin, help evaluate how well the brain and muscles work together and whether cerebellar pathways are affected.
Handwriting and fine-motor tasks
Asking the patient to write, draw spirals, or button clothing can reveal subtle dystonia or parkinsonism in the hands, which might not be obvious at rest but appear during precise movements.
Standardized dystonia rating scales
In specialist centers, clinicians may use formal rating scales to score the severity and distribution of dystonia. These scales help track change over time and response to manganese-lowering therapy.

Laboratory and Pathological Tests

Serum manganese level
Measuring manganese in blood is a key test. In this syndrome, serum manganese is clearly elevated and remains high, confirming that there is a systemic manganese overload that fits with the clinical picture.
Complete blood count (CBC) with hemoglobin and hematocrit
CBC usually shows high red blood cell count, high hemoglobin, and high hematocrit, confirming polycythemia or erythrocytosis, which is a hallmark of SLC30A10-related disease.
Liver function tests (AST, ALT, bilirubin, alkaline phosphatase)
Liver enzyme and bilirubin tests show whether the liver is inflamed or damaged. Many patients have raised liver enzymes or abnormal bilirubin, supporting the diagnosis of chronic liver disease due to manganese.
Coagulation profile (INR, PT, aPTT)
Tests that measure blood clotting help show how well the liver is working, because many clotting factors are made in the liver. Abnormal results can indicate advanced cirrhosis or poor liver function.
Iron studies and ferritin
Iron tests (serum iron, ferritin, transferrin saturation) are done because iron status affects manganese handling and because iron therapy is often used in treatment. These tests also help rule out other causes of polycythemia.
Tests to exclude other liver and movement disorders
Doctors often check markers for viral hepatitis, autoimmune liver disease, and copper and ceruloplasmin levels to rule out Wilson disease and other liver conditions that can mimic parts of the picture but do not cause hypermanganesemia with polycythemia.
Genetic testing for SLC30A10 mutations
Confirmatory diagnosis is made by genetic testing that looks for harmful changes in both copies of the SLC30A10 gene. Finding a biallelic pathogenic variant together with the typical clinical and MRI findings establishes the diagnosis.
Liver biopsy (in selected cases)
In some patients, a liver biopsy may be taken to look at the tissue under a microscope. It can show fibrosis or cirrhosis and, with special studies, may show metal deposition, but it is invasive and not always required if other tests are clear.

Electrodiagnostic Tests

Electromyography (EMG) for dystonia patterns
EMG can record muscle activity and show the typical co-contraction of opposing muscles seen in dystonia. While not specific to manganese overload, it can support the diagnosis of a dystonic movement disorder.
Electroencephalogram (EEG) if seizures are present
If a patient has seizures, EEG is used to record brain electrical activity and look for epileptic discharges. This test helps guide seizure management in those rare patients with both dystonia and epilepsy.

Imaging Tests

Brain MRI with special focus on basal ganglia
MRI of the brain is one of the most important tests. In this syndrome, the basal ganglia usually show very bright signal on T1-weighted images due to manganese deposition, which is a strong clue to an inherited manganese transport defect like SLC30A10 deficiency.
Liver ultrasound
Ultrasound of the liver is a simple, non-invasive imaging test that can show an enlarged liver, irregular liver surface, or signs of cirrhosis and portal hypertension, supporting the diagnosis of chronic liver disease.
Liver MRI or CT scan
MRI or CT of the liver can provide more detailed images, showing nodular changes, fibrosis, and blood-flow changes. These scans help stage the severity of cirrhosis and rule out other structural liver diseases.
Whole-body or targeted imaging for complications
In advanced cases, doctors may use additional imaging (such as Doppler ultrasound for portal vein, or chest imaging) to look for complications of cirrhosis or secondary problems related to chronic illness.
Follow-up MRI to monitor response to treatment
When manganese-lowering treatment is started, repeated brain MRI may show that the bright signal in the basal ganglia becomes less intense. This improvement on imaging can go along with clinical recovery and helps doctors track how well treatment is working.

Non-pharmacological Treatments (Therapies and Others)

Manganese-restricted diet
A dietitian may design a meal plan that reduces manganese intake but still gives enough calories, protein, vitamins, and minerals. This often means limiting very high-manganese foods such as tea, nuts, whole grains, and some leafy greens, while keeping overall nutrition balanced.[3]
Safe drinking water management
People with this syndrome should avoid well water or other sources known to have high manganese. Household filters or bottled water may be recommended after testing local water. Reducing manganese in water helps lower total body exposure and supports chelation therapy.[3][5]
Avoiding manganese-containing supplements
Many multivitamins or “trace mineral” products contain extra manganese. Patients are advised to avoid these products unless a specialist specifically prescribes them. This prevents additional manganese load that could worsen brain and liver injury.[3]
Occupational and environmental control
Exposure to manganese fumes (for example, welding, mining, battery work) should be avoided. Family members’ workplace exposures may also be checked to avoid bringing dust home on clothes or shoes. Reducing environmental manganese supports long-term disease control.[3]
Physical therapy for dystonia and gait
Physiotherapists teach stretching, strengthening, and balance exercises to reduce stiffness, prevent contractures, and improve walking. Regular guided exercise can lower fall risk and help patients keep independence even when dystonia is significant.[1][3]
Occupational therapy and adaptive devices
Occupational therapists suggest modified utensils, writing aids, seating, and bathroom supports to make daily tasks safer and easier. This can reduce fatigue, prevent injuries, and maintain school or work participation as much as possible.[1][3]
Speech and swallowing therapy
When dystonia affects facial, jaw, or throat muscles, speech-language therapists help improve speech clarity and teach safe swallowing techniques. This may lower the risk of choking and malnutrition and support better communication.[1][3]
Posture and seating management
Special chairs, cushions, and supportive braces can help maintain an upright posture and reduce painful muscle spasms. Proper positioning protects joints and skin and improves comfort for long sitting or wheelchair use.[1]
Fall-prevention and home safety changes
Simple changes like removing loose rugs, installing grab bars, adding night lights, and using non-slip shoes can greatly lower fall risk. This is important because dystonia and muscle stiffness make falls more likely and more dangerous.[1]
Liver-protective lifestyle (no alcohol or illicit drugs)
Alcohol and many illicit drugs can seriously worsen liver damage. Completely avoiding these substances is critical. Patients should also discuss any herbal or “detox” products with their doctors, as some can be toxic to the liver.[2][3]
Salt and fluid management for cirrhosis complications
For people with fluid buildup (ascites or leg swelling), reducing salt in the diet and following fluid advice from the liver specialist can help. This supports the effect of diuretic medicines and lowers pressure in the blood vessels of the abdomen.[2]
Vaccination against hepatitis A and B
Because the liver is already vulnerable, catching hepatitis A or B can be very dangerous. Vaccination (if not already immune) is strongly recommended to lower the risk of additional viral liver injury.[2][3]
Regular monitoring and follow-up
Scheduled check-ups usually include blood counts, liver function tests, manganese levels, and brain/liver imaging when needed. Close follow-up helps doctors adjust chelation, iron therapy, and supportive care before serious complications appear.[3][4]
Early family screening and genetic counselling
Brothers, sisters, and sometimes parents may be carriers or affected at an early stage. Genetic counselling and testing can allow earlier diagnosis, earlier treatment, and informed reproductive choices for families.[1][2][4]
Psychological support and counseling
Living with a rare, long-term condition is stressful for patients and families. Psychological support or counseling can help with anxiety, sadness, body-image worries, and school or work difficulties, improving quality of life.[1]
Educational support plans for children
Children may need flexible school schedules, assistive devices, or extra help with writing and movement. An individualized education plan can keep learning on track and reduce social isolation.[1]
Nutritional counseling for adequate calories and protein
Because chewing, swallowing, and fatigue can reduce food intake, a dietitian may design high-energy and high-protein meals, or suggest small frequent meals. This helps maintain weight and muscle strength.[2][3]
Support groups and rare-disease networks
Families often benefit from connecting with others facing similar conditions. Support groups can share practical tips, emotional help, and updates about research and clinical trials.[1]
Planning pregnancy and contraception with specialists
Adults with this syndrome should discuss pregnancy planning with liver and neurology specialists. Some medicines and chelation schedules may need changes before conception or during pregnancy.[2]
Care coordination in an expert center
Because HMDPC is extremely rare, care in a center experienced with inherited manganese disorders can improve treatment sequencing, monitoring, and access to research studies and new therapies.[3][4]

Drug Treatments

There is no single “magic pill” for this syndrome. Most drugs are used to remove manganese or treat dystonia, polycythemia, or cirrhosis complications. Doses below are typical ranges for adults; exact dosing must be individualized by specialists.

Edetate calcium disodium (CaNa₂EDTA)
This intravenous chelating agent binds metals like manganese and helps remove them through urine. It is FDA-approved for lead poisoning but widely reported as the main treatment for inherited hypermanganesemia, given in repeated 5-day courses under close monitoring.[3][4][5]
Disodium calcium edetate (Na₂CaEDTA) regimens
In many case reports, Na₂CaEDTA is infused in hospital or day-care settings at carefully calculated doses over several hours. Treatment cycles may be repeated monthly, with checks of kidney function, manganese level, zinc, and blood counts to watch for side effects.[3][4][5]
Oral iron (for example, ferrous sulfate)
Oral iron supplements are used to correct low iron stores and reduce manganese absorption from the gut by competing for the same transport pathways. This can help control polycythemia and lower manganese load, but iron must be monitored to avoid overload.[3][4][10]
Baclofen
Baclofen is a muscle-relaxant drug used to reduce dystonia and spasticity. It acts on GABA-B receptors in the spinal cord, decreasing excessive muscle activity. It is usually given several times a day and adjusted slowly to balance symptom relief and drowsiness or weakness.[1]
Clonazepam
Clonazepam is a benzodiazepine that can lessen dystonic spasms and anxiety. It enhances the effect of GABA, a calming neurotransmitter in the brain. Doctors start with a low dose at night and increase cautiously to avoid sedation, memory problems, or dependence.[1]
Trihexyphenidyl
This anticholinergic drug is sometimes used in generalized dystonia. It helps correct the chemical imbalance between acetylcholine and dopamine in movement pathways. Side effects such as dry mouth, blurry vision, constipation, and confusion are monitored carefully, especially in children.[1]
Levodopa/carbidopa
In patients who also show parkinsonian features (slowness, stiffness, tremor), a trial of levodopa/carbidopa may be tried. It supplies dopamine to the brain and carbidopa reduces side effects. Response is variable in manganese-related disorders and must be assessed by a movement-disorder specialist.[1][3]
Botulinum toxin type A injections
For focal dystonia (for example, neck, limbs, or face), botulinum toxin can be injected into overactive muscles to reduce abnormal posture and pain. The effect appears over days and lasts about 3 months. Doses are individualized to avoid too much weakness.[1]
Propranolol
Propranolol is a non-selective beta-blocker widely used in cirrhosis to reduce portal vein pressure and prevent bleeding from esophageal varices. In this syndrome, it may be used similarly when portal hypertension is present, with careful monitoring of blood pressure and heart rate.[2]
Low-dose aspirin
When polycythemia is marked, low-dose aspirin may be used to reduce the risk of blood clots by blocking platelet aggregation. It is used only when bleeding risk from cirrhosis and varices is judged acceptable by the treating hepatologist and hematologist.[2][4]
Hydroxyurea (selected cases of severe polycythemia)
Hydroxyurea reduces red blood cell production in the bone marrow. In rare severe cases where polycythemia persists despite chelation and iron correction, some clinicians may consider it, but data in HMDPC are very limited, and risks must be weighed carefully.[4]
Spironolactone
Spironolactone is a potassium-sparing diuretic commonly used for ascites in cirrhosis. It blocks aldosterone, reducing sodium and water retention. It is usually combined with dietary salt restriction and sometimes furosemide, while monitoring potassium and kidney function.[2]
Furosemide
Furosemide is a loop diuretic that helps remove excess fluid through the kidneys. When paired with spironolactone and low-salt diet, it can control leg swelling and ascites. Doctors adjust dose step by step to avoid dehydration or kidney injury.[2]
Lactulose
Lactulose is a non-absorbable sugar used to prevent or treat hepatic encephalopathy. It draws water into the bowel and changes gut bacteria, causing more ammonia to be removed in stool instead of reaching the brain. Soft, frequent stools are expected and monitored.[2]
Rifaximin
Rifaximin is a non-absorbable antibiotic that lowers ammonia-producing bacteria in the intestine. It is often used with lactulose in people with recurrent encephalopathy. It stays mainly in the gut, so systemic side effects are less common.[2]
Ursodeoxycholic acid
Ursodeoxycholic acid is a bile acid that can improve bile flow and reduce itching or cholestatic liver injury in some patients. Its role in HMDPC depends on the pattern of liver disease but may be considered by hepatologists when cholestasis is prominent.[2]
Zinc supplements
Prolonged EDTA chelation can lower zinc levels, so zinc may be replaced. Zinc is also important for many enzymes and immune function. Doses are chosen to correct deficiency without adding to metal imbalance and are checked with blood tests.[3][5]
Vitamin E (as a drug-strength antioxidant)
Vitamin E is a fat-soluble antioxidant; in some chronic liver diseases, it has been studied as a way to reduce oxidative stress in liver cells. In this syndrome it might be considered as supportive care, but it does not replace chelation or other standard treatments.[2][3]
Analgesics for pain and muscle spasms
Paracetamol (acetaminophen) at safe liver-adjusted doses or carefully chosen other pain medicines may be used when dystonia or muscle cramps are painful. Dosing must consider liver function and avoid drugs that are clearly hepatotoxic or increase bleeding risk.[2]
Antidepressants or anxiolytics (case-by-case)
Long-term neurological disability and chronic illness can cause depression or anxiety. SSRIs or other antidepressants may be prescribed when needed, with close monitoring for side effects and interactions with existing liver disease and neurological medications.[1]

Dietary Molecular Supplements

(Evidence for these supplements is generally indirect, based on liver disease, oxidative stress, or neurological injury in other conditions. They should only be used under medical supervision.)

Vitamin C
Vitamin C is a water-soluble antioxidant that helps protect cells from oxidative stress and supports collagen formation and wound healing. It may support general health in chronic liver and neurological disease but does not remove manganese by itself.[2][3]
Vitamin E
Vitamin E helps protect cell membranes from free-radical damage. In some fatty liver and chronic liver diseases it has been studied as a supportive therapy. In HMDPC it may be used as an add-on antioxidant, not a primary treatment.[2][3]
N-acetylcysteine (NAC)
NAC is a precursor of glutathione, a major antioxidant in liver cells. It is widely used in acetaminophen poisoning and studied in other liver conditions. It may help reduce oxidative stress but must be used with liver specialist guidance.[2]
Omega-3 fatty acids
Omega-3 fatty acids from fish oil may improve triglycerides, reduce inflammation, and support brain health. In cirrhosis, they are sometimes used as nutritional support, but doses should be discussed with doctors to avoid bleeding risks from high doses.[2]
S-adenosylmethionine (SAMe)
SAMe participates in methylation reactions and glutathione production in the liver. It has been studied in some chronic liver diseases. In this syndrome it may be a supportive agent to help liver cell defenses but cannot replace chelation and standard care.[2][3]
L-carnitine
L-carnitine helps transport fatty acids into mitochondria for energy production. It has been explored in some liver disorders and muscle conditions to improve energy and reduce fatigue, but evidence in HMDPC is limited and use remains supportive.[2]
Thiamine (Vitamin B1)
Thiamine is essential for carbohydrate metabolism and nerve function. Correcting any deficiency is important in patients with poor appetite, vomiting, or malnutrition, and helps prevent Wernicke encephalopathy and peripheral neuropathy.[2]
Folate (Folic acid)
Folate helps DNA synthesis and red blood cell formation. In patients with chronic illness and dietary limitations, folate supplementation can prevent macrocytic anemia and support overall blood health, though it does not correct manganese overload.[2]
Selenium
Selenium is part of antioxidant enzymes such as glutathione peroxidase. Adequate selenium may help cell protection in chronic liver disease, but excessive doses can be toxic. Any supplementation should be based on measured levels and specialist advice.[2][3]
Zinc (nutritional doses)
Beyond replacement for chelation-induced deficiency, appropriate nutritional zinc supports immune function, wound healing, and taste. However, zinc balance must be monitored carefully in the context of metal metabolism disorders and EDTA therapy.[3][5]

Immunity-Booster / Regenerative / Stem-Cell-Related Approaches

At present, there are no FDA-approved stem-cell or gene-therapy drugs specifically for this syndrome. The approaches below are experimental or conceptual and should only be considered in clinical trials or expert centers.

Mesenchymal stem-cell infusions for cirrhosis (research)
Mesenchymal stem cells from bone marrow or umbilical cord are being studied in advanced liver disease to support regeneration and reduce inflammation. Early trials show mixed results, and these therapies remain experimental, with unknown long-term safety.[2][3]
Hepatocyte or liver cell transplantation (research)
Transplanting healthy liver cells into a diseased liver is being explored as a bridge or alternative to full liver transplantation. For SLC30A10-related disease this is still theoretical and would not replace chelation therapy.[2]
Induced pluripotent stem-cell (iPSC)–based therapies (research)
Patient-derived iPSCs can be corrected in the lab and turned into neurons or hepatocytes for research. In the future, such cells might be used therapeutically, but this is far from routine clinical use and carries major safety and ethical questions.[3]
Experimental gene-therapy targeting SLC30A10 (conceptual)
Future gene-therapy approaches might aim to deliver a normal SLC30A10 gene to liver and brain cells to restore manganese export. Currently, this idea is at research level only and not available as a treatment.[3][13]
Immunization and infection prevention as “immune support”
Routine and liver-specific vaccines (e.g., hepatitis A and B, influenza, pneumococcal) are crucial to protect a vulnerable liver and overall health. Good infection prevention acts as a practical way to “boost” immune resilience without unproven immune-boosting drugs.[2]
Nutritional and lifestyle immune support
Adequate sleep, balanced diet, physical activity within ability, and avoiding smoking and alcohol all support normal immune function and tissue repair. These simple measures are safer and more evidence-based than most marketed “immune boosters.”[2][3]

Surgeries and Procedures

Liver biopsy
Liver biopsy may be used early in the disease to confirm cirrhosis, evaluate severity, and rule out other causes of liver injury. It guides treatment planning, though non-invasive tests are increasingly used when possible.[2]
Endoscopic variceal ligation
If large esophageal veins (varices) develop from portal hypertension, endoscopic band ligation may be performed to prevent or treat life-threatening bleeding. This is usually combined with beta-blocker therapy and careful follow-up.[2]
Transjugular intrahepatic portosystemic shunt (TIPS)
TIPS places a small channel inside the liver to connect portal and hepatic veins, lowering portal pressure. It is used in selected patients with recurrent variceal bleeding or difficult ascites, after weighing risks such as encephalopathy.[2]
Deep brain stimulation (DBS)
DBS surgery places electrodes in specific brain areas linked to movement. In severe, disabling generalized dystonia that does not respond to medicines, DBS may reduce abnormal movements and improve function. Decisions are made in specialized movement-disorder centers.[1]
Liver transplantation
In advanced cirrhosis or liver failure, liver transplantation may be considered. It replaces the diseased liver with a healthy one, which can improve survival, but lifelong immunosuppression and very careful manganese management are required.[2][3]

Key Preventions

Early genetic testing and diagnosis in at-risk families.[1][2]
Avoidance of manganese-rich water and occupational exposures.[3]
Avoidance of manganese-containing supplements unless prescribed.[3]
Regular surveillance of manganese levels, blood counts, and liver tests.[3][4]
Prompt start and correct scheduling of chelation therapy when indicated.[3][4][5]
Strict avoidance of alcohol and hepatotoxic drugs or herbs.[2]
Vaccination against hepatitis A and B and other key infections.[2]
Early treatment of dystonia and gait problems to prevent falls and contractures.[1]
Family counselling to prevent delayed diagnosis in siblings.[1][4]
Care in experienced centers familiar with inherited manganese disorders.[3]

When to See Doctors Urgently

People with this syndrome should contact their doctor or emergency services immediately if they notice: sudden worsening of confusion, sleepiness, or personality changes; vomiting blood or passing black stools; rapid abdominal swelling; severe shortness of breath or chest pain; new weakness or inability to walk; or high fever and signs of serious infection.[1][2]

They should also arrange prompt review if they notice gradually increasing stiffness or abnormal postures, new tremors, worsening balance, new jaundice (yellow eyes or skin), intense itching, new headaches, or sudden changes in blood counts on routine tests.[1][2][3]

Dietary “What to Eat and What to Avoid” Points

Eat: Balanced meals with adequate calories, protein, fruits, and vegetables to maintain strength and weight.[2][3]
Eat: Soft, easy-to-chew foods and small frequent meals if chewing or swallowing is difficult.[1]
Eat: Healthy fats like olive oil and modest amounts of nuts or seeds, adjusted for manganese advice from the dietitian.[3]
Eat: Foods rich in vitamins and antioxidants (fruits, vegetables), within any liver-related restrictions.[2]
Eat: Enough fluid to stay hydrated, respecting any fluid limits set by the liver specialist.[2]
Avoid: Alcohol completely and energy drinks or products with unknown herbal ingredients.[2]
Avoid: Manganese-fortified supplements or “trace mineral” mixes unless prescribed.[3]
Avoid: Very salty processed foods (chips, instant noodles, cured meats) if ascites or swelling is present.[2]
Avoid: Raw or undercooked shellfish, which can carry dangerous infections for people with cirrhosis.[2]
Avoid: Extreme fad diets or fasting that can cause muscle loss and weakness.[2][3]

Frequently Asked Questions (FAQs)

Is HMDPC a genetic disease?
Yes. It is caused by harmful changes in both copies of the SLC30A10 gene. Parents are usually healthy carriers and have a 25% chance of having an affected child in each pregnancy.[1][2]
How rare is this condition?
HMDPC is extremely rare, with only a small number of families reported worldwide. Many doctors may never see a case, which is why referral to specialist centers is important.[1][3]
What age do symptoms usually start?
Symptoms often begin in childhood with movement problems, difficulty walking, or abnormal postures. Liver and blood changes may appear around the same time or later, depending on the individual.[1][2]
Can chelation therapy really help?
Case reports show that EDTA-based chelation plus iron therapy can lower manganese levels, improve MRI changes, and lead to better movement and blood counts, especially when started early.[3][4][22]
Does treatment cure the disease?
Treatment can control manganese levels and slow or prevent some damage, but it does not remove the underlying genetic change. Lifelong monitoring and, often, repeated treatment cycles are needed.[2][3]
Will every patient develop severe cirrhosis?
Not necessarily. Early diagnosis and effective manganese removal appear to reduce the risk and severity of cirrhosis in many patients, although careful liver monitoring is still required.[2][3][22]
Is brain damage reversible?
Some improvements in MRI findings and movement symptoms have been reported after chelation, particularly in younger patients, but long-standing damage may be only partly reversible.[3][4]
Can patients attend school or work?
Many can, especially when movement problems and liver disease are well managed and appropriate support is provided. Individual education and workplace adjustments are often helpful.[1]
Is pregnancy possible with this condition?
Pregnancy may be possible but requires careful planning with liver and neurology specialists. Some medicines, including chelation regimens, may need to be modified before and during pregnancy.[2]
Is ordinary tap water safe?
Water safety depends on local manganese levels. Tests may be recommended, and filters or alternative water sources may be used if levels are high.[3]
Should all family members be tested?
Genetic counselling is recommended. Siblings and sometimes extended relatives may be offered genetic testing or screening of manganese levels and blood counts, especially in communities where consanguinity is common.[1][4]
Are “detox” products or heavy-metal cleanses helpful?
No. Unregulated detox products can be harmful to the liver and kidneys and do not replace evidence-based chelation therapy supervised by specialists.[2][3]
Can manganese be measured easily?
Whole blood manganese can be measured in specialized laboratories. MRI of the brain often shows characteristic changes that support the diagnosis and can track treatment response.[1][3]
Is there a patient registry or research network?
Because the disease is very rare, patient registries and research networks are being developed in some regions to collect data, improve care, and support clinical trials.[3][22][30]
Where can families find expert care?
Families are usually referred to centers with experience in inherited metabolic and movement disorders or specialized liver units. Genetic counsellors and rare-disease organizations can help locate such centers.[1][3]

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: January 26, 2025.

PDF Documents For This Disease Condition

References

SaveSavedRemoved 0